- Home
- VRTX vs SE Comparison
VRTX vs SE Comparison
Compare VRTX & SE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTX
- SE
- Stock Information
- Founded
- VRTX 1989
- SE 2009
- Country
- VRTX United States
- SE Singapore
- Employees
- VRTX N/A
- SE N/A
- Industry
- VRTX EDP Services
- SE Other Consumer Services
- Sector
- VRTX Technology
- SE Consumer Discretionary
- Exchange
- VRTX Nasdaq
- SE Nasdaq
- Market Cap
- VRTX 115.6B
- SE 93.4B
- IPO Year
- VRTX 1991
- SE 2017
- Fundamental
- Price
- VRTX $462.13
- SE $154.20
- Analyst Decision
- VRTX Buy
- SE Buy
- Analyst Count
- VRTX 25
- SE 10
- Target Price
- VRTX $509.00
- SE $153.70
- AVG Volume (30 Days)
- VRTX 1.1M
- SE 4.0M
- Earning Date
- VRTX 08-04-2025
- SE 08-12-2025
- Dividend Yield
- VRTX N/A
- SE N/A
- EPS Growth
- VRTX N/A
- SE 2223.84
- EPS
- VRTX N/A
- SE 1.42
- Revenue
- VRTX $11,099,700,000.00
- SE $17,926,637,000.00
- Revenue This Year
- VRTX $10.43
- SE $30.04
- Revenue Next Year
- VRTX $10.81
- SE $20.56
- P/E Ratio
- VRTX N/A
- SE $108.41
- Revenue Growth
- VRTX 8.98
- SE 30.31
- 52 Week Low
- VRTX $377.85
- SE $55.00
- 52 Week High
- VRTX $519.88
- SE $172.65
- Technical
- Relative Strength Index (RSI)
- VRTX 49.57
- SE 46.09
- Support Level
- VRTX $460.55
- SE $153.47
- Resistance Level
- VRTX $474.76
- SE $162.22
- Average True Range (ATR)
- VRTX 9.12
- SE 5.69
- MACD
- VRTX -1.34
- SE -0.29
- Stochastic Oscillator
- VRTX 28.52
- SE 18.13
About VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About SE Sea Limited each representing one
Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid C2C and B2C marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue generating game. Sea's third business, SeaMoney, provides lending, payment, digital banking, and insurance services.As of March 31, 2024, Forrest Xiaodong Li, the founder, chairman and CEO, owned 59.8% of voting power and 18.5% of issued shares. Tencent owned 18.2% of issued shares with no voting power.